Tony DiMaio
Head of Investor Relations, Amniel Pharmaceuticals
Replay available
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) Q1 2026 earnings conference call, held 2026-05-01. Replay captured from the company's public earnings webcast.

Head of Investor Relations, Amniel Pharmaceuticals
Co-founder and Co-CEO, Amniel Pharmaceuticals
Co-founder and Co-CEO, Amniel Pharmaceuticals
Chief Financial Officer, Amniel Pharmaceuticals
Analyst, Goldman Sachs
Analyst, Truist Securities
Analyst, Piper Sandler
Analyst, JPMorgan
Watch the replay and follow the connected company analysis, news, and investor updates for Amneal Pharmaceuticals, Inc..
WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a0425d-75bf-77c0-9888-30168f3d41b5 Created: 2026-08-27T08:37:01.074Z Duration: 3661.0874 Channels: 1 00:00:00.000 -- 00:00:03.679 Good morning, and welcome to today's Amneal Pharmaceuticals 00:00:03.679 -- 00:00:04.960 Investor Call. 00:00:05.520 -- 00:00:07.040 I will now turn the call over to 00:00:07.040 -- 00:00:09.120 Amneal's Head of Investor Relations, 00:00:09.200 -- 00:00:10.400 Tony DeMeo. 00:00:12.240 -- 00:00:13.120 Good morning, 00:00:13.635 -- 00:00:16.355 and thank you for joining Amneal Pharmaceuticals' 00:00:16.355 -- 00:00:17.315 investor call. 00:00:17.555 -- 00:00:20.035 This morning, we issued a press release announcing 00:00:20.035 -- 00:00:21.475 Amneal agrees 00:00:21.475 -- 00:00:23.635 to acquire Kashyyb Biosciences 00:00:23.795 -- 00:00:26.355 and reporting preliminary q one results. 00:00:27.060 -- 00:00:28.980 The press release and presentation 00:00:29.060 -- 00:00:31.300 are available at amneal.com. 00:00:31.700 -- 00:00:34.500 Certain statements made on this call regarding matters 00:00:34.500 -- 00:00:36.340 that are not historical facts, 00:00:36.660 -- 00:00:39.775 including but not limited to management's outlook or 00:00:39.775 -- 00:00:43.055 predictions are forward looking statements that are based 00:00:43.055 -- 00:00:45.935 solely on information that is now available to 00:00:45.935 -- 00:00:46.495 us. 00:00:47.135 -- 00:00:50.335 Please see the section entitled Cautionary Statements on 00:00:50.335 -- 00:00:53.455 Forward Looking Statements for Factors that May Impact 00:00:53.455 -- 00:00:54.415 Future Performance. 00:00:55.170 -- 00:00:57.649 We also discuss non GAAP measures. 00:00:57.969 -- 00:01:00.930 Information on use of these measures and reconciliations 0...